JP2005287985A - Inflammation/odor suppressing member, manufacturing method thereof, and prosthesis and cast using it - Google Patents

Inflammation/odor suppressing member, manufacturing method thereof, and prosthesis and cast using it Download PDF

Info

Publication number
JP2005287985A
JP2005287985A JP2004110713A JP2004110713A JP2005287985A JP 2005287985 A JP2005287985 A JP 2005287985A JP 2004110713 A JP2004110713 A JP 2004110713A JP 2004110713 A JP2004110713 A JP 2004110713A JP 2005287985 A JP2005287985 A JP 2005287985A
Authority
JP
Japan
Prior art keywords
inflammation
copper
silver
base material
control member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004110713A
Other languages
Japanese (ja)
Inventor
Yuichiro Matsuo
勇一郎 松尾
Takayasu Ikeda
孝保 池田
Takehiro Ohashi
武洋 大橋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GHA KK
Original Assignee
GHA KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GHA KK filed Critical GHA KK
Priority to JP2004110713A priority Critical patent/JP2005287985A/en
Publication of JP2005287985A publication Critical patent/JP2005287985A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C28/00Coating for obtaining at least two superposed coatings either by methods not provided for in a single one of groups C23C2/00 - C23C26/00 or by combinations of methods provided for in subclasses C23C and C25C or C25D

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Metallurgy (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Prostheses (AREA)
  • Other Surface Treatments For Metallic Materials (AREA)

Abstract

<P>PROBLEM TO BE SOLVED: To provide an inflammation/odor suppressing member which suppresses inflammation of a skin in an environment where irritation of the skin is easily triggered, and suppresses an odor. <P>SOLUTION: The inflammation/odor suppressing member has anodized coatings provided at least at a part of a surface of a main body of a base material made of aluminum or an aluminum alloy, one kind or more than two kinds of metals out of silver, copper, gold, and platinum deposited at least at a part of the anodized coatings, and a nonwoven fabric provided at least at a part of the surface of the main body of the base material. The irritation and the itching at the end part of amputated hands and legs and the odor in an attaching socket are suppressed, and the occurrence of phantom limbs felt by people wearing prosthetic limbs is reduced by attaching the inflammation/odor suppressing member to the inner surface of the attaching socket of the prosthetic limb. <P>COPYRIGHT: (C)2006,JPO&NCIPI

Description

本発明は、皮膚の炎症及び/又は臭いの発生を抑制する炎症/臭い抑制部材(この明細書を通して、炎症及び/又は臭い抑制部材を「炎症/臭い抑制部材」として表現する)及びこれを製造するための製造方法、並びにこの炎症/臭い抑制部材を用いた義体及びギブスに関する。   The present invention relates to an inflammation / odor control member that suppresses the occurrence of skin inflammation and / or odor (throughout this specification, the inflammation and / or odor control member is expressed as “inflammation / odor control member”) and to produce the same And a prosthesis and a cast using the inflammation / odor control member.

例えば、交通事故などで脚及びその下の部分を切断した人は、膝より近位の脚に切断した脚の代用として義足を取り付け、この義足を利用して歩行している。このような義体の一例としての義足は、切断した脚の切断端に装着される装着ソケット(所謂、大腿ソケット)と、歩行するための足部とを備え、装着ソケットと足部とが膝軸を介して連結され、歩行の際に装着ソケットに対して足部が屈曲、伸展するようになっている(例えば、特許文献1参照)。   For example, a person who has cut a leg and a lower part thereof due to a traffic accident or the like attaches a prosthetic leg as a substitute for the cut leg to a leg proximal to the knee, and walks using this prosthetic leg. A prosthetic leg as an example of such a prosthetic body includes a mounting socket (a so-called thigh socket) to be attached to a cut end of a cut leg and a foot for walking, and the mounting socket and the foot are knees. It is connected via a shaft so that the foot bends and extends with respect to the mounting socket during walking (see, for example, Patent Document 1).

特開平11−19105号公報Japanese Patent Laid-Open No. 11-19105

このような義足の使用状態においては、脚の切断端部が装着ソケット内に挿入されてほぼ密閉した状態に保たれ、装着ソケット内の環境状態は非常に悪い状態になる。それ故に、汗、脂分などの分泌物によって蒸れやすく、また雑菌が繁殖し易い状態となる。従って、夏場などにおいては蒸れが原因となって皮膚がかぶれたり、またこれが原因となって痒みが生じたりすることがある。また、このように蒸れ易い環境では、繁殖した雑菌などによって悪臭が生じ易くなる。このようなことから、義足を装着した人は、皮膚の炎症による蒸れ、痒みなどに悩まされ、時には幻肢痛(手足の切断後も、手足が残っているように痛みや痒みを感じること)に悩むことがある。また、義足を取り外したときに、周囲に悪臭が漂うことがある。   In such a state of use of the artificial leg, the cut end portion of the leg is inserted into the mounting socket and kept in a substantially sealed state, and the environmental condition in the mounting socket becomes very bad. Therefore, it becomes easy to be stuffy due to secretions such as sweat and fat, and it is easy for bacteria to propagate. Therefore, in summer, the skin may be irritated due to stuffiness, and itching may occur due to this. Further, in such an easily sultry environment, malodors are likely to occur due to various germs that have propagated. For this reason, people wearing prosthetic legs are bothered by stuffiness and itching due to skin inflammation, and sometimes phantom limb pain (feeling pain and itching as if the limbs remain even after limb amputation) You may be troubled. Also, when the prosthetic leg is removed, there may be a bad smell around it.

このような問題を解消するためには、義足の装着ソケット内を清潔に保つことが一つの方法であるが、清潔に保つために一日の装着時間が長い義足を洗浄、消毒するのは非常に煩雑で、また洗浄、消毒に時間を要し、義足使用者にとって大きな負担になっている。   One way to solve this problem is to keep the prosthetic leg socket clean, but in order to keep it clean, prosthetic legs that have been worn for a long time are very clean and disinfected. In addition, it takes time for cleaning and disinfection, which is a heavy burden on the prosthetic leg user.

また、手(又は腕)を切断した人は、義体の他の例としての義手を使用しており、この義手も腕の切断端に装着される装着ソケットを備えており、使用状態においては、義手の装着ソケット内もほぼ密閉した状態に保たれ、装着ソケット内の環境状態が非常に悪いことから、義足による上述した問題と同様の問題がある。   In addition, the person who cut the hand (or arm) uses a prosthetic hand as another example of a prosthetic body, and this prosthetic hand also has a mounting socket to be attached to the cut end of the arm. Since the mounting socket of the prosthetic hand is also kept in a substantially sealed state and the environmental condition in the mounting socket is very bad, there is a problem similar to that described above with the prosthetic leg.

また、脚、腕などを骨折したときには、骨接ぎ治療のためにギブスが使用される。このギブスを使用した状態においても、ギブス内がほぼ密閉した状態に保たれ、その使用環境が非常に悪く、上述した義体と同様の問題がある。   Moreover, when a leg, an arm, or the like is broken, a cast is used to treat the bone. Even in the state where the cast is used, the interior of the cast is kept almost sealed, the use environment is very bad, and there is a problem similar to the above-mentioned prosthetic body.

本発明の目的は、皮膚のかぶれ易い環境において、皮膚の炎症、臭いの発生を抑制することができるとともに、皮膚にも優しい炎症/臭い抑制部材を提供することである。
また、本発明の他の目的は、皮膚の炎症によるかぶれ、痒みなどの発生、また臭いの発生を抑えるとともに、皮膚にも優しい義体及びギブスを提供することである。
An object of the present invention is to provide an inflammation / odor control member that can suppress skin irritation and odor generation in an environment in which skin irritation tends to occur, and that is also gentle to the skin.
Another object of the present invention is to provide a prosthetic body and a cast that are gentle to the skin while suppressing the occurrence of rash and itching due to inflammation of the skin and the generation of odor.

また、本発明の更に他の目的は、表面処理によって炎症抑制効果、臭い抑制効果を持たせることができる炎症/臭い抑制部材の製造方法を提供することである。   Still another object of the present invention is to provide a method for producing an inflammation / odor control member capable of having an inflammation suppression effect and an odor suppression effect by surface treatment.

本発明の請求項1に記載の炎症/臭い抑制部材は、アルミニウム又はその合金から形成された母材本体の表面の少なくとも一部に陽極酸化被膜を設け、前記陽極酸化被膜の少なくとも一部に銀、銅、金及び白金のいずれか一種又は二種以上の金属を析出させ、前記母材本体の表面の少なくとも一部を不織布で覆ったことを特徴とする。   The inflammation / odor control member according to claim 1 of the present invention is provided with an anodized film on at least a part of a surface of a base material body formed of aluminum or an alloy thereof, and silver is formed on at least a part of the anodized film. One or more metals of copper, gold and platinum are deposited, and at least a part of the surface of the base material body is covered with a nonwoven fabric.

また、本発明の請求項2に記載の炎症/臭い抑制部材は、母材本体の表面の少なくとも一部に酸化チタン膜を設け、前記母材本体の表面の少なくとも一部を不織布で覆ったことを特徴とする。   The inflammation / odor control member according to claim 2 of the present invention is provided with a titanium oxide film on at least a part of the surface of the base material main body, and at least a part of the surface of the base material main body is covered with a nonwoven fabric. It is characterized by.

また、本発明の請求項3に記載の義体は、請求項1又は2に記載の炎症/臭い抑制部材と、人体の一部に装着するための装着ソケットとを備え、前記炎症/臭い抑制部材を前記装着ソケットの内面に装着して皮膚表面に不織布を介して密着保持し、前記炎症/臭い抑制部材の析出金属又は酸化チタン膜の抗菌作用により皮膚表面の炎症発生を抑制し、前記装着ソケット内の臭い発生を抑制することを特徴とする。   A prosthetic body according to claim 3 of the present invention comprises the inflammation / odor control member according to claim 1 or 2 and a mounting socket for mounting on a part of a human body, and the inflammation / odor control. A member is attached to the inner surface of the mounting socket and is closely adhered to the skin surface via a nonwoven fabric, and the inflammation / odor control member prevents the occurrence of inflammation on the skin surface by the antibacterial action of the deposited metal or titanium oxide film. It is characterized by suppressing the generation of odor in the socket.

また、本発明の請求項4に記載のギブスは、請求項1又は2に記載の炎症/臭い抑制部材と、人体に一部に装着されるギブス本体とを備え、前記炎症/臭い抑制部材を前記ギブス本体の内面側に配設して皮膚表面に不織布を介して保持し、前記炎症/臭い抑制部材の析出金属又は酸化チタン膜の抗菌作用により皮膚表面の炎症を抑制し、前記ギブス本体内の臭い発生を抑制することを特徴とする。   Moreover, the cast of Claim 4 of this invention is equipped with the inflammation / odor suppression member of Claim 1 or 2, and the Gibbs main body with which a human body is mounted | worn in part, The said inflammation / odor suppression member is provided. Arranged on the inner surface side of the Gibbs body and held on the skin surface via a non-woven fabric, suppresses inflammation on the skin surface by the antibacterial action of the deposited metal or titanium oxide film of the inflammation / odor control member, It is characterized by suppressing the generation of odor.

また、本発明の請求項5に記載の炎症/臭い抑制部材の製造方法は、アルミニウム又はその合金から形成された母材本体を、硫酸浴又はシュウ酸浴或いはこれらの混合浴中に硝酸銀、硫酸銀、硝酸銅及び硫酸銅のいずれか、或いは硝酸銀又は硫酸銀と硝酸銅又は硫酸銅との混合物を添加した電解液中にて、交直重畳電流、マイナス波を流すPR電流、又はマイナス波を流すパルス若しくは交流電流のいずれかを加えて電解処理し、これによって、前記部材本体の表面に陽極酸化被膜を形成すると同時に、添加した硝酸銀、硫酸銀、硝酸銅又は硫酸銅の金属をこの陽極酸化被膜に析出させ、その後、このように表面処理した母材本体の表面の少なくとも一部に不織布を設けたことを特徴とする。   According to a fifth aspect of the present invention, there is provided a method for producing an inflammation / odor control member comprising: a base material body made of aluminum or an alloy thereof, silver nitrate, sulfuric acid in a sulfuric acid bath, an oxalic acid bath, or a mixed bath thereof. In an electrolytic solution to which silver, copper nitrate, or copper sulfate, or a mixture of silver nitrate or silver sulfate and copper nitrate or copper sulfate is added, an AC / DC superimposed current, a PR current that passes a negative wave, or a negative wave is passed Electrolytic treatment is performed by applying either a pulse or an alternating current, thereby forming an anodic oxide film on the surface of the member body, and simultaneously adding the added silver nitrate, silver sulfate, copper nitrate or copper sulfate metal to the anodic oxide film. It is characterized in that a nonwoven fabric is provided on at least a part of the surface of the base material main body which has been deposited on the surface and then surface-treated in this way.

また、本発明の請求項6に記載の炎症/臭い抑制部材の製造方法は、アルミニウム又はその合金から形成された母材本体を、硫酸浴又はシュウ酸浴或いはこれらの混合浴中に浸漬してその表面に陽極酸化被膜を形成し、その後、硝酸銀、硫酸銀、硝酸銅及び硫酸銅のいずれか、或いは、硝酸銀又は硫酸銀と硝酸銅又は硫酸銅との混合物を添加した電解液中にて、交直重畳電流、マイナス波を流すPR電流、マイナス波を流すパルス又は交流電流のいずれかを加えて電解処理し、これによって、添加した硝酸銀、硫酸銀、硝酸銅又は硫酸銅の金属を陽極酸化被膜に析出させ、次いで、このように表面処理した母材本体の表面の少なくとも一部に不織布を設けたことを特徴とする。   In the method for producing an inflammation / odor control member according to claim 6 of the present invention, a base material body formed of aluminum or an alloy thereof is immersed in a sulfuric acid bath, an oxalic acid bath, or a mixed bath thereof. An anodized film is formed on the surface, and then, in an electrolytic solution to which silver nitrate, silver sulfate, copper nitrate and copper sulfate, or a mixture of silver nitrate or silver sulfate and copper nitrate or copper sulfate is added, Electrolytic treatment is performed by applying either AC / DC superimposing current, negative wave PR current, negative wave pulse or alternating current, and the added silver nitrate, silver sulfate, copper nitrate or copper sulfate metal is anodized. Then, a non-woven fabric is provided on at least a part of the surface of the base material main body which has been precipitated and then surface-treated in this way.

本発明の請求項1に記載の炎症/臭い抑制部材によれば、母材本体に陽極酸化被膜が形成され、この陽極酸化被膜に銀、銅、金及び白金の一種又は二種以上の金属が析出されているので、この炎症/臭い抑制部材が湿度の高い環境中にあると、析出した金属がイオン化されて不織布を通って周囲に放出される。析出した金属は抗菌作用があり、この金属から放出された金属イオン(銀、銅、金、白金のイオン)は更に強い抗菌作用を発揮する。従って、このように金属イオンが放出されると、その強い抗菌作用によって、汗、脂分などの分泌物により蒸れやすくて雑菌が繁殖し易い皮膚表面においても、雑菌の繁殖が著しく抑えられて減少し、これによって、皮膚表面のかぶれ、痒みなどの発生を抑えることができる。また、雑菌が減少するので、その繁殖による臭いもほとんど発生することがなく、臭いの発生も抑制することができる。この陽極酸化被膜の形成は母材本体の少なくとも一部又は全部でよく、また金属の析出も陽極酸化被膜の少なくとも一部又は全部でよい。尚、この炎症/臭い抑制部材使用は、皮膚表面のかぶれなどが発生し易い部分にこの炎症/臭い抑制部材を接触乃至密着保持すればよい。   According to the inflammation / odor control member according to claim 1 of the present invention, an anodic oxide film is formed on the base material main body, and one or two or more kinds of metals of silver, copper, gold and platinum are formed on the anodic oxide film. When deposited, if the inflammation / odor control member is in a high humidity environment, the deposited metal is ionized and released to the surroundings through the nonwoven fabric. The deposited metal has an antibacterial action, and metal ions (silver, copper, gold, platinum ions) released from the metal exert a stronger antibacterial action. Therefore, when metal ions are released in this way, their strong antibacterial action significantly reduces the growth of germs even on the skin surface where the germs are easily stuffy due to secretions such as sweat and fat. Thus, it is possible to suppress the occurrence of skin irritation, itching and the like. Further, since the number of germs is reduced, there is almost no odor due to the breeding, and the generation of odor can be suppressed. The anodic oxide film may be formed on at least a part or all of the base material body, and the metal may be deposited on at least a part or all of the anodic oxide film. In addition, the use of the inflammation / odor suppressing member may be performed by contacting or holding the inflammation / odor suppressing member in contact with a portion where skin surface irritation or the like is likely to occur.

また、母材本体の表面の少なくとも一部を不織布で覆っているので、この不織布が皮膚を保護し、その表面を傷つけることがない。この不織布は皮膚と接触する部分の全域に設けるのが好ましく、このように構成することによって、不織布を介して皮膚表面に接触乃至密着され、母材本体の硬い感じによる不快感が生じず、また、例えば金属アレルギーの人の場合でもそのまま使用することができるので取扱いが容易である。尚、不織布は例えばメッシュ状に形成されており、このメッシュの大きさは金属イオンの大きさよりも十分大きいので、金属イオンは不織布を通して周囲に放出され、上述した効果を生じることができる。   Moreover, since at least a part of the surface of the base material body is covered with the nonwoven fabric, the nonwoven fabric protects the skin and does not damage the surface. This non-woven fabric is preferably provided over the entire area in contact with the skin, so that the non-woven fabric is brought into contact with or in close contact with the skin surface through the non-woven fabric, and no uncomfortable feeling due to the hard feeling of the base material body occurs. For example, even in the case of a person who is allergic to metal, it can be used as it is, so it is easy to handle. The nonwoven fabric is formed in a mesh shape, for example, and the size of the mesh is sufficiently larger than the size of the metal ions, so that the metal ions are released to the surroundings through the nonwoven fabric, and the above-described effects can be produced.

また、本発明の請求項2に記載の炎症/臭い抑制部材によれば、母材本体の表面の少なくとも一部に酸化チタン膜が設けられている。酸化チタンは、酸化効果のある活性酸素を発生し、この活性酸素が表面に付着した有機物を分解することによって消臭及び抗菌といった作用を生じる。このような消臭、抗菌作用を有する酸化チタンの膜を母材本体の表面の少なくとも一部に設けることによって、汗、脂分などの分泌物により蒸れやすくて雑菌が繁殖し易い皮膚表面においても、雑菌の繁殖が抑えられ、これによって皮膚表面のかぶれ、痒みなどの発生を抑えることができ、また雑菌による臭いの発生も抑えることができる。尚、酸化チタンは、一般的に光が当たることによって消臭、抗菌作用を生ずるが、光が当たらなくてもこのような作用をするものもあり、このような酸化チタンを用いることによって、光が当たらないところでも消臭、抗菌作用が得られる。また母材本体の表面に設けられた不織布による効果は、上述したのと同様である。   According to the inflammation / odor control member according to claim 2 of the present invention, the titanium oxide film is provided on at least a part of the surface of the base material body. Titanium oxide generates active oxygen having an oxidizing effect, and the active oxygen decomposes organic substances adhering to the surface, thereby producing deodorizing and antibacterial actions. By providing such a deodorizing and antibacterial titanium oxide film on at least a part of the surface of the base material body, it is easy to get stuffy due to secretions such as sweat and fat, and on the skin surface where bacteria can easily propagate. It is possible to suppress the propagation of various germs, thereby suppressing the occurrence of rash, itching and the like on the skin surface, and also the generation of odor due to the various germs. Titanium oxide generally produces deodorant and antibacterial effects when exposed to light, but some of these functions even when not exposed to light. Deodorant and antibacterial action can be obtained even if it is not hit. The effect of the nonwoven fabric provided on the surface of the base material body is the same as described above.

また、本発明の請求項3に記載の義体又は請求項4に記載のギブスによれば、人体の一部に装着される装着ソケット又はギブス本体に炎症/臭い抑制部材が装着され、この炎症/臭い抑制部材が人体の一部の切断端部又は骨折治療部の皮膚表面に不織布を介して接触される。   Moreover, according to the artificial body according to claim 3 of the present invention or the cast of claim 4, the inflammation / odor control member is mounted on the mounting socket or the body of the cast that is mounted on a part of the human body. The odor control member is brought into contact with the cut surface of a part of the human body or the skin surface of the fracture treatment unit via a nonwoven fabric.

義体とは義手、義足などの人体の一部を代用させたものであり、脚を切断した人は、脚の切断端部に義足の装着ソケットを取り付けて使用し、また手(腕)を切断した人は、腕の切断端部に義手の装着ソケットを取り付けて使用するようになる。例えば、義足の使用状態においては、脚の切断端部が装着ソケット内に挿入され、装着ソケット内はほぼ密封状態に保たれ、夏場などにおいては使用環境が非常に悪い状態にある。このような使用環境において、脚の切断端部からの汗、脂分などの分泌物が分泌されると、これら分泌物により雑菌が非常に繁殖し易い状態になり、このようなことが原因となって、脚の切断端部のかぶれ、痒みなどが生じていた。装着ソケット内面に、脚の切断端部に接触するように炎症/臭い抑制部材を装着すると、炎症/臭い抑制部材による抗菌作用によって雑菌の繁殖が抑えられて減少し、これによって、雑菌を原因とする脚の切断端部のかぶれ、痒みなどの発生が抑制されるとともに、装着ソケット内の臭いの発生も抑制される。従って、この炎症/臭い抑制部材を義手、義足などの義体に使用することによって、それらの使用状態の環境を改善し、義体の装着者に清潔で不快感のない使用環境を提供することができる。   A prosthetic body is a substitute for a part of the human body, such as a prosthetic hand or a prosthetic leg. A person who has cut off a leg uses a prosthetic leg mounting socket at the cut end of the leg, and uses a hand (arm). The person who cuts the arm uses the prosthetic hand mounting socket attached to the cut end of the arm. For example, when the prosthetic leg is in use, the cut end portion of the leg is inserted into the mounting socket, the inside of the mounting socket is maintained in a substantially sealed state, and the usage environment is very bad in summer. In such a use environment, when secretions such as sweat and fat from the cut end of the leg are secreted, these secretions make it easy for germs to propagate. As a result, the cut end of the leg was irritated and itchy. When the inflammation / odor control member is attached to the inner surface of the mounting socket so as to contact the cut end of the leg, the antibacterial action of the inflammation / odor control member suppresses and reduces the propagation of various bacteria. Occurrence of rash, itch and the like at the cut end portion of the leg to be performed is suppressed, and generation of odor in the mounting socket is also suppressed. Therefore, by using this inflammation / odor control member for a prosthetic body such as a prosthetic hand, a prosthetic leg, etc., to improve the environment of the state of use thereof, and to provide a clean and uncomfortable use environment for the prosthetic wearer Can do.

義手、義足などの装着者は、また、幻肢に悩ませることがある。幻肢とは、手足の切断前の記憶が消去できずに頭の中で混乱している状態であり、手足が切断されて存在しないのに切断された手足が残っているように痛みや痒みを感じることであり、義手、義足の装着状態における不快感の現れの一つとも言われている。この炎症/臭い抑制部材を使用すると、脚(腕)の切断端部における雑菌への抗菌作用が発揮され、雑菌の繁殖が抑えられ、この切断端部の皮膚の状態を改善させることができる。従って、使用による不快感がほとんど取り除かれ、不快な幻肢痛、幻肢かゆみを大幅に軽減させることができる。   Wearers such as prosthetic hands and prosthetic legs may also suffer from phantom limbs. The phantom limb is a state in which the memory before the amputation of the limbs cannot be erased and is confused in the head. It is said to be one of the manifestations of discomfort in the state of wearing a prosthetic hand and a prosthetic leg. When this inflammation / odor control member is used, the antibacterial action against germs at the cut end of the leg (arm) is exhibited, the propagation of germs is suppressed, and the skin condition at the cut end can be improved. Therefore, the discomfort due to use is almost eliminated, and unpleasant phantom limb pain and phantom limb itch can be greatly reduced.

また、例えば、ギブスの使用状態においても、骨折などの治療部位がギブス本体で覆われ、ギブス本体内がほぼ密封状態に保たれ、義足などの義体と同様に、夏場などにおいては使用環境が非常に悪い状態にあるが、このギブス本体内に炎症/臭い抑制部材を配設することによって、その抗菌作用、消臭作用によって使用環境の大幅な改善を図り、ギブス装着者に清潔で不快感のない使用環境を提供することができる。   Also, for example, even when the cast is in use, the treatment site such as a fracture is covered with the cast, and the interior of the cast is kept almost sealed. Although it is in a very bad state, by placing an inflammation / odor control member in the body of this cast, the use environment is greatly improved by its antibacterial and deodorizing effects, and it is clean and uncomfortable for the caster. It is possible to provide a use environment without any problem.

炎症/臭い抑制部材としては、陽極酸化被膜に銀、銅、金、白金を析出させたもの、特に銀、銅を析出させたものは抗菌作用が非常に強く、装着者により良い使用環境を提供することができ、従って、かぶれや痒みの発生が非常に抑制され、また臭いの発生も大幅に抑制することができる。   Inflammation / odor control members with silver, copper, gold, and platinum deposited on the anodized film, particularly those with silver and copper, have a very strong antibacterial action and provide a better environment for wearers Therefore, the occurrence of rash and itching can be greatly suppressed, and the generation of odor can be greatly suppressed.

また、本発明の請求項5に記載の表面処理方法によれば、電解液として硫酸浴又はシュウ酸浴或いはこれらの混合浴が用いられ、この電解浴中に硝酸銀、硫酸銀、硝酸銅及び硫酸銅のいずれか、或いは硝酸銀又は硫酸銀と硝酸銅又は硫酸銅との混合物が添加される。そして、電解液中に交直重畳電流、マイナス波を流すPR電流、又はマイナス波を流すパルス若しくは交流電流のいずれかを加えて電解処理が行われるので、アルミニウム又はその合金から形成された母材本体の表面に陽極酸化被膜が形成されると同時に、その陽極酸化被膜に添加した硝酸銀、硫酸銀、硝酸銅又は硫酸銅の金属(銀、銅)が析出され、一度の電解処理でもって陽極酸化被膜の形成及び銀又は銅の析出を行うことができる。そして、このような表面処理の後に、その表面の少なくとも一部に不織布が設けられる。このように製造した炎症/臭い抑制部材では、湿度の高い環境中においては析出した金属(銀、銅)がイオン化されて、不織布を通って周囲に放出され、強い抗菌作用を発揮し、それ故に、雑菌による皮膚の炎症を抑制する炎症抑制部材として、また雑菌による臭いの発生を抑制する臭い抑制部材として用いることができる。尚、不織布は、プレス加工などによって母材本体と一体的になるように設けるのが好ましい。   According to the surface treatment method of claim 5 of the present invention, a sulfuric acid bath, an oxalic acid bath or a mixed bath thereof is used as an electrolytic solution, and silver nitrate, silver sulfate, copper nitrate and sulfuric acid are used in the electrolytic bath. Either copper or a mixture of silver nitrate or silver sulfate and copper nitrate or copper sulfate is added. And, since the electrolytic treatment is performed by applying either AC / DC superimposed current, PR current that flows minus waves, or pulse or AC current that flows minus waves in the electrolyte, the base material body formed of aluminum or its alloy At the same time as the anodic oxide film is formed on the surface of the metal, silver nitrate, silver sulfate, copper nitrate or copper sulfate metal (silver, copper) added to the anodic oxide film is deposited. And silver or copper deposition. And after such a surface treatment, a nonwoven fabric is provided in at least one part of the surface. In the thus produced inflammation / odor control member, the deposited metal (silver, copper) is ionized and released to the surroundings through the nonwoven fabric in a high humidity environment, and thus exerts a strong antibacterial action. It can be used as an inflammation suppressing member that suppresses inflammation of the skin caused by various bacteria, and as an odor suppressing member that suppresses the generation of odor caused by various bacteria. In addition, it is preferable to provide a nonwoven fabric so that it may become integral with a base-material main body by press work etc.

また、本発明の請求項6に記載の表面処理方法によれば、硫酸浴又はシュウ酸浴或いはこれらの混合浴が用いられ、この電解浴中に部材本体を浸漬して電解処理するので、その表面に陽極酸化被膜が形成される。その後、第2回目の電解処理として、硫酸銀、硝酸銀、硝酸銅、硫酸銅のいずれか、或いは硝酸銀又は硫酸銀と硝酸銅又は硫酸銅との混合物を添加した電解液が用いられ、この電解浴中にて、交直重畳電流、マイナス波を流すPR電流、マイナス波を流すパルス又は交流電流のいずれかを加えて電解処理するので、陽極酸化被膜に添加した硝酸銀、硫酸銀、硝酸銅又は硫酸銅の金属(銀、銅)が析出され、このように表面処理することによっても銀又は銅の析出を行うことができる。このように表面処理した後に、母材本体の表面の少なくとも一部に不織布が設けられる。このように製造した炎症/臭い抑制部材でも、上述したと同様に、金属イオンが不織布を通って周囲に放出されることによって強い抗菌作用を発揮し、それ故に、雑菌による皮膚の炎症を抑制する炎症抑制部材として、また雑菌による臭いの発生を抑制する臭い抑制部材として、更には幻肢痛を抑制する抑制部材として用いることができる。   According to the surface treatment method of claim 6 of the present invention, a sulfuric acid bath, an oxalic acid bath or a mixed bath thereof is used, and the member body is immersed in the electrolytic bath for electrolytic treatment. An anodized film is formed on the surface. Thereafter, as the second electrolytic treatment, an electrolytic solution in which any of silver sulfate, silver nitrate, copper nitrate, copper sulfate, or a mixture of silver nitrate or silver sulfate and copper nitrate or copper sulfate is added is used. Electrolytic treatment is performed by adding either AC / DC superimposed current, negative current PR current, negative current pulse or AC current, so silver nitrate, silver sulfate, copper nitrate or copper sulfate added to the anodized film The metal (silver, copper) is deposited, and silver or copper can be deposited by surface treatment in this way. After the surface treatment in this way, a nonwoven fabric is provided on at least a part of the surface of the base material body. The inflammation / odor control member manufactured in this way also exerts a strong antibacterial action by releasing metal ions to the surroundings through the nonwoven fabric, as described above, and therefore suppresses skin inflammation caused by various bacteria. It can be used as an inflammation suppressing member, as an odor suppressing member that suppresses the generation of odor due to various bacteria, and further as a suppressing member that suppresses phantom limb pain.

以下、添付図面を参照して、本発明に従う炎症/臭い抑制部材及びその製造方法並びにそれを用いた義体及びギブスについて説明する。
まず、図1を参照して、本発明に従う炎症/臭い抑制部材の製造方法について説明する。図1は、本発明に従う製造方法を実施するために用いる表面処理装置の一例を簡略的に示す簡略図である。
Hereinafter, an inflammation / odor control member according to the present invention, a manufacturing method thereof, and a prosthetic body and a cast using the same will be described with reference to the accompanying drawings.
First, with reference to FIG. 1, the manufacturing method of the inflammation / odor control member according to this invention is demonstrated. FIG. 1 is a simplified diagram schematically showing an example of a surface treatment apparatus used for carrying out the manufacturing method according to the present invention.

図1において、図示の表面処理装置は、直方体状の電解槽2を備え、この電解槽2内の両側部に電極4,6が配設されている。この形態では、電極4,6は、電解槽2の長手方向、図1において左右方向に間隔をおいて配設された4個のプレート状電極8,10から構成され、これらプレート状電極8,10がカーボンから形成されている。電極4,6は電気的に並列に配置され、一方の電極4の4個のプレート状電極8は電気的に直列に接続され、他方の電極6の4個のプレート状電極10は電気的に直列に接続されている。   In FIG. 1, the illustrated surface treatment apparatus includes a rectangular parallelepiped electrolytic cell 2, and electrodes 4 and 6 are disposed on both sides of the electrolytic cell 2. In this embodiment, the electrodes 4 and 6 are composed of four plate-like electrodes 8 and 10 arranged at intervals in the longitudinal direction of the electrolytic cell 2 and in the left-right direction in FIG. 10 is formed from carbon. The electrodes 4 and 6 are electrically arranged in parallel, the four plate electrodes 8 of one electrode 4 are electrically connected in series, and the four plate electrodes 10 of the other electrode 6 are electrically connected. Connected in series.

一対の電極4,6の間に表面処理すべき母材本体12,14、具体的には表面処理すべき部材12,14が配設される。一方の母材本体12は電極4に対向してその内側に配設され、他方の母材14は電極6に対向してその内側に配設される。かかる母材12,14は、アルミニウム又はアルミニウム合金から形成され、その形状は、例えば薄い箔状、薄いプレート状、繊維状、細長いワイヤ状などに形成される。この表面処理装置は、アルミニウム又はその合金から形成された母材本体12,14に後述する如くして表面処理を行う。   Between the pair of electrodes 4 and 6, base material bodies 12 and 14 to be surface-treated, specifically, members 12 and 14 to be surface-treated are disposed. One base material body 12 is disposed on the inside facing the electrode 4, and the other base material 14 is disposed on the inside facing the electrode 6. The base materials 12 and 14 are made of aluminum or an aluminum alloy, and the shape thereof is formed into, for example, a thin foil shape, a thin plate shape, a fiber shape, an elongated wire shape, or the like. In this surface treatment apparatus, the base material bodies 12 and 14 formed of aluminum or an alloy thereof are subjected to surface treatment as described later.

この電解槽2内には、表面処理するための電解液が充填され、処理すべき母材本体12,14はこの電解液中に浸漬される。電解液としては、硫酸浴又はシュウ酸浴或いはこれらの混合浴が用いられる。そして、このような電解浴に金属の硝酸塩として硝酸銀又は硝酸銅、又は金属の硫酸塩として硫酸銀又は硫酸銅、或いは硝酸銀又は硝酸銅と硫酸銀又は硫酸銅との混合物が添加される。硫酸浴を用いる場合、硫酸が例えば100〜300g/リットルの割合で溶解され、シュウ酸浴を用いる場合、シュウ酸が例えば20〜40g/リットルの割合で溶解される。   The electrolytic cell 2 is filled with an electrolytic solution for surface treatment, and the base material bodies 12 and 14 to be treated are immersed in the electrolytic solution. As the electrolytic solution, a sulfuric acid bath, an oxalic acid bath, or a mixed bath thereof is used. Then, silver nitrate or copper nitrate as the metal nitrate, or silver sulfate or copper sulfate as the metal sulfate, or a mixture of silver nitrate or copper nitrate and silver sulfate or copper sulfate is added to such an electrolytic bath. When using a sulfuric acid bath, sulfuric acid is dissolved at a rate of, for example, 100 to 300 g / liter, and when using an oxalic acid bath, oxalic acid is dissolved at a rate of, for example, 20 to 40 g / liter.

また、このような電解浴に添加される硝酸銀又は硫酸銀は、例えば2〜12g/リットルの割合で加えられる。硝酸銀又は硫酸銀が2g/リットルより少なくなると、表面処理を行ったときの銀の析出量が少なくなり、また硝酸銀又は硫酸銀が12g/リットルを超えると、表面処理を行ったときに陽極酸化被膜にピット(孔食)が発生して被膜欠陥が発生し易くなる。   Moreover, silver nitrate or silver sulfate added to such an electrolytic bath is added at a rate of 2 to 12 g / liter, for example. If the amount of silver nitrate or silver sulfate is less than 2 g / liter, the amount of silver deposited when the surface treatment is performed decreases, and if the amount of silver nitrate or silver sulfate exceeds 12 g / liter, the anodized film is formed when the surface treatment is performed. Pits (pitting corrosion) occur in the film, and film defects are likely to occur.

また、硝酸銀や硫酸銀に代えて、硝酸銅や硫酸銅を添加するようにしてもよく、この場合にも、添加される硝酸銅又は硫酸銅は、例えば2〜12g/リットルの割合で加えられる。硝酸銅又は硫酸銅が2g/リットルより少なくなると、表面処理を行ったときの銅の析出量が少なくなり、また硝酸銅又は硫酸銅が12g/リットルを超えると、表面処理を行ったときに陽極酸化被膜にピット(孔食)が発生して被膜欠陥が発生し易くなる。   Further, instead of silver nitrate or silver sulfate, copper nitrate or copper sulfate may be added. In this case, the added copper nitrate or copper sulfate is added at a rate of 2 to 12 g / liter, for example. . When the amount of copper nitrate or copper sulfate is less than 2 g / liter, the amount of copper deposited when the surface treatment is performed decreases, and when the amount of copper nitrate or copper sulfate exceeds 12 g / liter, the anode is formed when the surface treatment is performed. Pits (pitting corrosion) occur in the oxide film, and film defects are likely to occur.

母材本体12,14に表面処理を施す際、母材本体12,14に交直重畳の電流、即ち交流電流と直流電流のプラス側電流とを重畳させた電流が加えられ、このような電流を加えて母材本体12,14に電解処理を施す。この形態では、直流電源16のプラス側がリアクタ18に電気的に接続され、またこの直流電源16のマイナス側が電極4,6(プレート状電極8,10)に電気的に接続される。更に、交流電源20がリアクタ18に電気的に接続され、リアクタ18は直流電源16のプラス側の電流を交流電源20からの交流電流に重畳し、重畳した重畳電流を処理すべき母材本体12,14に送給する。   When surface treatment is performed on the base metal bodies 12 and 14, an AC / DC superimposed current, that is, a current in which an alternating current and a positive current of a DC current are superimposed is applied to the base body bodies 12 and 14, and such a current is applied. In addition, the base metal bodies 12 and 14 are subjected to electrolytic treatment. In this embodiment, the positive side of the DC power supply 16 is electrically connected to the reactor 18, and the negative side of the DC power supply 16 is electrically connected to the electrodes 4 and 6 (plate-like electrodes 8 and 10). Furthermore, the AC power source 20 is electrically connected to the reactor 18, and the reactor 18 superimposes the positive current of the DC power source 16 on the AC current from the AC power source 20, and the base material body 12 to process the superimposed superimposed current. , 14.

表面処理時には、電流密度が例えば1〜10A/dmの範囲になるように選定され、この電流密度が所定設定時間継続して通電される。電流密度が10A/dmを超えると、表面処理によって形成される陽極酸化被膜にヤケ等の変色が発生し易く、また母材本体12,14とこれを保持する治具との接触部に放電による損傷が発生し易くなる。一方、電流密度が1A/dmより小さくなると、電解液中を流れる電流が小さく、表面処理の処理効率が悪くなる。 During the surface treatment, the current density is selected to be in the range of, for example, 1 to 10 A / dm 2 and the current density is continuously energized for a predetermined set time. When the current density exceeds 10 A / dm 2 , discoloration such as burns easily occurs in the anodized film formed by the surface treatment, and discharge occurs at the contact portion between the base material bodies 12 and 14 and the jig holding the same. It is easy to cause damage. On the other hand, when the current density is smaller than 1 A / dm 2 , the current flowing in the electrolyte is small, and the surface treatment efficiency is deteriorated.

この表面処理時、電解浴の温度は例えば−10〜25℃の範囲になるように選定される。電解浴の温度が25℃を超えると、母材本体12,14の表面に生成される陽極酸化被膜が軟質化し、場合によっては平坦な被膜が得られなくなる。一方、電解浴の温度が−10℃より低くなると、表面処理の処理効率が悪くなり、表面処理コストが増大する。   At the time of this surface treatment, the temperature of the electrolytic bath is selected to be in the range of, for example, −10 to 25 ° C. When the temperature of the electrolytic bath exceeds 25 ° C., the anodized film formed on the surfaces of the base material bodies 12 and 14 becomes soft, and in some cases, a flat film cannot be obtained. On the other hand, when the temperature of the electrolytic bath is lower than −10 ° C., the treatment efficiency of the surface treatment is deteriorated and the surface treatment cost is increased.

上述した表面処理装置でもって母材本体12,14に表面処理を施すと、母材本体12,14の表面は図2に示す通りに形成される。母材本体12,14の一部を拡大して示す図2を参照して、上述した表面処理を行うと、アルミニウム又はその合金から形成された母材本体12,14の表面に陽極酸化被膜22(所謂、アルマイト被膜)が形成される。この陽極酸化被膜22は、母材本体12,14の表面に形成されるバリヤ層24と、このバリヤ層24の表面に形成される多孔質層26とから構成され、バリヤ層24の厚さは約0.01〜0.1μm程度に、また多孔質層26の厚さは約10〜200μm程度に形成される。   When the surface treatment is performed on the base material bodies 12 and 14 using the surface treatment apparatus described above, the surfaces of the base material bodies 12 and 14 are formed as shown in FIG. Referring to FIG. 2 showing a part of base material bodies 12 and 14 in an enlarged manner, when the surface treatment described above is performed, anodized film 22 is formed on the surfaces of base material bodies 12 and 14 formed of aluminum or an alloy thereof. (So-called alumite coating) is formed. The anodized film 22 is composed of a barrier layer 24 formed on the surfaces of the base material bodies 12 and 14 and a porous layer 26 formed on the surface of the barrier layer 24. The thickness of the barrier layer 24 is as follows. The porous layer 26 is formed to have a thickness of about 0.01 to 0.1 μm and a thickness of the porous layer 26 of about 10 to 200 μm.

上述した表面処理方法で処理すると、多孔質層26に多数存在する孔28内に硝酸銀(又は硫酸銀)の銀30、或いは硝酸銅(又は硫酸銅)の銅が析出する。このように銀30(又は銅)が析出するので、母材本体12,14に抗菌性が付与され、この母材本体12,14を使用することによって、雑菌の繁殖を抑え、清潔な状態に保つことができる。特に、上述した処理方法によって析出した銀30(又は銅)は、水分の多い環境では(例えば、水に浸けたり、多湿の環境下に置くと)、銀(又は銅)がイオン化して周囲に放出され、イオン化した銀(又は銅)が強い抗菌作用を発揮する。 上述した実施形態では、表面処理する際に交直重畳の電流を加えて電解処理しているが、交直重畳電流に代えて、マイナス波を流すPR電流、マイナス波を流すパルス又は交流電流を加えるようにしても、上述したと同様に、1回の電解処理でもって所定の表面処理を行うことができ、母材本体12,14の表面に上記陽極酸化被膜22を形成するとともに、形成した陽極酸化被膜22に銀30(又は銅)を析出させることができる。   When the surface treatment method described above is used, silver nitrate (or silver sulfate) silver 30 or copper nitrate (or copper sulfate) copper is deposited in a large number of holes 28 present in the porous layer 26. Since silver 30 (or copper) precipitates in this way, antibacterial properties are imparted to the base material bodies 12 and 14, and by using the base material bodies 12 and 14, the propagation of various bacteria is suppressed and the clean state is maintained. Can keep. In particular, the silver 30 (or copper) deposited by the above-described processing method is ionized by the silver (or copper) being ionized in an environment with a lot of moisture (for example, when immersed in water or placed in a humid environment). Released and ionized silver (or copper) exerts a strong antibacterial action. In the embodiment described above, the electrolytic treatment is performed by applying an AC / DC superimposed current at the time of the surface treatment, but instead of the AC / DC superimposed current, a PR current for passing a negative wave, a pulse for passing a negative wave, or an AC current is added. However, as described above, a predetermined surface treatment can be performed by a single electrolytic treatment, and the anodic oxide coating 22 is formed on the surfaces of the base material bodies 12 and 14, and the formed anodic oxidation is performed. Silver 30 (or copper) can be deposited on the coating 22.

また、上述した実施形態では、一回の電解処理でもって母材本体12,14の表面に陽極酸化被膜22を形成すると同時に、この陽極酸化被膜22に銀30又は銅を析出させているが、陽極酸化被膜22の形成と、銀30又は銅の析出とを別の工程で行うようにしてもよい。この場合、母材本体12,14を硫酸浴又はシュウ酸浴或いはこれらの混合浴に浸漬して陽極酸化処理を施し、その後、硝酸銀又は硫酸銀(或いは、硝酸銅又は硫酸銅)を添加した電解液でもって電解処理すればよく、このようにしても同様に、陽極酸化被膜の形成と、この陽極酸化被膜への銀又は銅の析出を行うことができる。尚、この場合には、電解処理の電流としては種々の電流、例えば商業用電源である交流、交直重畳電流、マイナス波を流すPR電流又はマイナス波を流すパルス電流等の電流を加えることによって所定の電解処理を行うことができる。   In the above-described embodiment, the anodic oxide coating 22 is formed on the surfaces of the base material bodies 12 and 14 by a single electrolytic treatment, and at the same time, silver 30 or copper is deposited on the anodic oxide coating 22. The formation of the anodized film 22 and the deposition of silver 30 or copper may be performed in separate steps. In this case, the base metal bodies 12 and 14 are immersed in a sulfuric acid bath, an oxalic acid bath or a mixed bath thereof and subjected to an anodizing treatment, and then electrolysis in which silver nitrate or silver sulfate (or copper nitrate or copper sulfate) is added. In this way, the anodic oxide film can be formed and silver or copper can be deposited on the anodic oxide film. In this case, the current of the electrolytic treatment is determined by adding various currents, for example, currents such as alternating current, AC / DC superimposed current, PR current flowing negative waves, or pulse current flowing negative waves, which are commercial power sources. The electrolytic treatment can be performed.

また、上述した実施形態では、1回(又は2回)の電解処理によって陽極酸化被膜の表面に銀(又は銅)を析出しているが、抗菌効果を発揮する金又は白金を析出するようにしてもよい。   In the above-described embodiment, silver (or copper) is deposited on the surface of the anodic oxide coating by one (or two) electrolytic treatment, but gold or platinum exhibiting an antibacterial effect is deposited. May be.

上述したようにして表面処理を行った後、母材本体12,14の表面に不織布32を設ける。図3及び図4に示すように、不織布32は表面処理された母材本体12,14の両面に全面を覆うように設けられるが、その片面に設けるようにしてもよく、その表面の少なくとも一部に設けるようにしてもよく、皮膚表面と接触する部位に設けるのが望ましい。かかる不織布32は、例えば、母材本体12,14の両面側に不織布32を配設し、所定圧力でもってプレス加工を施すことによって、不織布32による通気性を確保しながら母材本体12,14と一体化することができる。このように一体化することに代えて、不織布で袋状部材を予め形成し、この袋状部材内に収容するようにしてもよい。このように製造される炎症/臭い抑制部材の特徴については、後述する。   After performing the surface treatment as described above, the nonwoven fabric 32 is provided on the surfaces of the base material bodies 12 and 14. As shown in FIGS. 3 and 4, the nonwoven fabric 32 is provided so as to cover the entire surface of the surface-treated base material bodies 12, 14, but may be provided on one side, and at least one of the surfaces thereof may be provided. It may be provided at the part, and is preferably provided at a site in contact with the skin surface. For example, the non-woven fabric 32 is provided with the non-woven fabric 32 on both sides of the base material bodies 12 and 14 and is pressed with a predetermined pressure, thereby ensuring the breathability of the non-woven fabric 32 and the base material bodies 12 and 14. And can be integrated. Instead of integrating in this way, a bag-like member may be formed in advance with a non-woven fabric and housed in the bag-like member. The characteristics of the inflammation / odor control member manufactured in this way will be described later.

上述した実施形態では、銀、銅、金及び白金の一種又は二種以上を析出しているが、このような析出に代えて、母材本体に酸化チタン膜を設けるようにしてもよい。この場合、母材本体は、例えばアルミニウム、ステンレス鋼、銅、鉄などの金属材料、又は、それらが繊維状となった金属繊維である。酸化チタン膜は、母材本体に公知の処理方法、例えば高温で母材本体に酸化チタンを塗布して形成することができる。このように酸化チタン膜を設けた場合においても、母材本体の表面の酸化チタン膜によって発生する活性酸素の作用による消臭及び抗菌作用によって、不快な臭いを抑えることができるとともに、雑菌の繁殖を抑えることができる。   In the embodiment described above, one or more of silver, copper, gold, and platinum are deposited. However, instead of such deposition, a titanium oxide film may be provided on the base material body. In this case, the base material body is, for example, a metal material such as aluminum, stainless steel, copper, or iron, or a metal fiber in which they are in the form of fibers. The titanium oxide film can be formed by applying a known processing method to the base material body, for example, applying titanium oxide to the base material body at a high temperature. Even when a titanium oxide film is provided in this way, an unpleasant odor can be suppressed by the deodorization and antibacterial action due to the action of active oxygen generated by the titanium oxide film on the surface of the base material body, and the propagation of various bacteria Can be suppressed.

上述した表面処理及び不織布32の被覆によって製造される炎症/臭い抑制部材は、皮膚の炎症を抑制するための炎症抑制部材として、及び/又は臭いの発生を抑制する臭い抑制部材として用いることができ、義体及びギブスなどに好都合に適用することができる。   The inflammation / odor suppressing member produced by the surface treatment and the coating of the nonwoven fabric 32 described above can be used as an inflammation suppressing member for suppressing skin inflammation and / or as an odor suppressing member for suppressing the generation of odor. It can be conveniently applied to prosthetics, gibbs and the like.

次に、図5を参照して、炎症/臭い抑制部材を義足に適用した例について説明する。図示の義足52は、切断した脚の切断端部に装着される装着ソケット54(所謂、大腿ソケット)と、歩行のための足部56とを備え、装着ソケット54の下端部と足部56の上端部とが膝軸58を介して連結され、装着ソケット54に対して足部56が屈曲、進展できるように構成されている。装着ソケット54の上端部には装着凹部60が設けられ、この装着凹部60の上面が開放されている。この装着ソケット54の装着凹部60に切断した脚の大腿切断端部62が挿入するように装着される。   Next, an example in which the inflammation / odor suppressing member is applied to the artificial leg will be described with reference to FIG. The illustrated artificial leg 52 includes a mounting socket 54 (so-called thigh socket) to be mounted on the cut end portion of the cut leg and a foot portion 56 for walking, and the lower end portion of the mounting socket 54 and the foot portion 56. The upper end portion is connected via a knee shaft 58, and the foot portion 56 is configured to bend and advance with respect to the mounting socket 54. A mounting recess 60 is provided at the upper end of the mounting socket 54, and the upper surface of the mounting recess 60 is open. The mounting socket 54 is mounted so that the cut thigh cut end 62 of the leg is inserted into the mounting recess 60.

このような義足52では、上述した如くして製造された炎症/臭い抑制部材64は、装着ソケット54の内面に装着される。この形態では、装着ソケット54の内面の所定部位には取付凹部63が設けられ、炎症/臭い抑制部材64はこの取付凹部63に収容するように取り付けられる。炎症/臭い抑制部材64は薄いプレート状に形成され、その両面が不織布32(図3、図4参照)に覆われ、不織布32が大腿切断端部62の皮膚表面に接触乃至密着するように装着ソケット54に取り付けられる。尚この形態では、装着ソケット54の取付凹部63に収容するように構成されているが、炎症/臭い抑制部材64の厚さが薄い場合、取付凹部63を設けることなく、装着ソケット54の内面に直接的に取り付けるようにしてもよい。   In such an artificial leg 52, the inflammation / odor control member 64 manufactured as described above is mounted on the inner surface of the mounting socket. In this embodiment, a mounting recess 63 is provided at a predetermined portion on the inner surface of the mounting socket 54, and the inflammation / odor suppressing member 64 is mounted so as to be accommodated in the mounting recess 63. The inflammation / odor control member 64 is formed in a thin plate shape, and both surfaces thereof are covered with the nonwoven fabric 32 (see FIGS. 3 and 4), and the nonwoven fabric 32 is attached so as to be in contact with or in close contact with the skin surface of the thigh cut end 62. It is attached to the socket 54. In this embodiment, it is configured to be accommodated in the mounting recess 63 of the mounting socket 54. However, when the inflammation / odor control member 64 is thin, the mounting recess 54 is not provided on the inner surface of the mounting socket 54. You may make it attach directly.

炎症/臭い抑制部材64を上述したように装着した義足52では、次の通りの特徴を有する。脚の切断端部62に装着ソケット54を装着した状態では、図5から理解されるように、装着ソケット54内はほぼ密封状態に保たれ、使用環境が非常に悪い状態にあり、脚の切断端部62からの汗、脂分などの分泌物が分泌されると、これら分泌物により雑菌が非常に繁殖し易く、この雑菌の繁殖などが原因となって、脚の切断端部62のかぶれ、痒みが生じるとともに、装着ソケット54の装着凹部60内に不快な臭いが生じるという問題がある。このような問題に対して、炎症/臭い抑制部材64を装着した義足52を用いると、炎症/臭い抑制部材64による抗菌作用、特に析出した銀30から放出される銀イオン(又は酸化チタン膜から発生した活性酸素)による強い抗菌作用によって雑菌の繁殖が抑えられて減少し、これによって、雑菌を原因とする脚の切断端部62のかぶれ、痒みなどの発生が抑制されるとともに、装着ソケット54の装着凹部60内の臭いの発生も抑制され、義足52を清潔に不快感のない状態に保つことができる。また、義足52の装着者は幻肢に悩ませることがあるが、脚の切断端部62における雑菌への抗菌作用が発揮されて雑菌の繁殖が抑えられる故に、この切断端部62の皮膚の状態を改善することができ、これによって、使用による不快感がほとんど取り除かれ、不快な幻肢痛、幻肢かゆみをも大幅に軽減することができる。   The artificial leg 52 to which the inflammation / odor suppressing member 64 is attached as described above has the following characteristics. When the mounting socket 54 is attached to the cut end 62 of the leg, as can be understood from FIG. 5, the inside of the mounting socket 54 is kept in a substantially sealed state, and the usage environment is very bad. When secretions such as sweat and fat from the end 62 are secreted, miscellaneous bacteria can be easily propagated by these secretions, and the rash of the cut end 62 of the leg is caused by the propagation of these miscellaneous bacteria. There are problems that itching occurs and an unpleasant odor is generated in the mounting recess 60 of the mounting socket 54. In response to such problems, when the prosthetic foot 52 equipped with the inflammation / odor control member 64 is used, the antibacterial action of the inflammation / odor control member 64, particularly silver ions released from the precipitated silver 30 (or from the titanium oxide film). Due to the strong antibacterial action due to the generated active oxygen), the propagation of various germs is suppressed and reduced, whereby the occurrence of rash and itching of the cut end 62 of the leg due to the various germs is suppressed, and the mounting socket 54 Odor generation in the mounting recess 60 is also suppressed, and the artificial leg 52 can be kept clean and uncomfortable. Although the wearer of the prosthetic leg 52 may suffer from phantom limbs, the antibacterial effect on the germs at the cut end 62 of the leg is exerted and the propagation of the germs is suppressed. The condition can be improved, so that discomfort due to use is almost eliminated, and unpleasant phantom limb pain, phantom limb itching can be greatly reduced.

加えて、この義足52では、炎症/臭い抑制部材64の表面が不織布32(図3、図4参照)により覆われているので、この不織布32によって脚の切断端部62を保護することができ、炎症/臭い抑制部材64の母材本体12,14が直接的に皮膚表面に接触して皮膚を傷つけることを防止することができる。尚、不織布32は通気性を有する故に、炎症/臭い抑制部材64の析出金属から放出された金属イオン(例えば、銀イオン)が不織布32を通して周囲に流れ、これによって、装着ソケット54内に収容された切断端部62の皮膚表面の実質上全域に行き渡らせることができる。   In addition, in this artificial leg 52, since the surface of the inflammation / odor control member 64 is covered with the nonwoven fabric 32 (see FIGS. 3 and 4), the cut end portion 62 of the leg can be protected by the nonwoven fabric 32. It is possible to prevent the base material bodies 12 and 14 of the inflammation / odor control member 64 from directly contacting the skin surface and damaging the skin. Since the nonwoven fabric 32 has air permeability, metal ions (for example, silver ions) released from the deposited metal of the inflammation / odor control member 64 flow to the surroundings through the nonwoven fabric 32, and are thereby accommodated in the mounting socket 54. The cut end 62 can be spread over substantially the entire skin surface.

図5においては、炎症/臭い抑制部材64を義体としての義足52に装着した例について説明したが、義足52に限定されず、義体としての義手などにも同様に適用することができる。   In FIG. 5, the example in which the inflammation / odor suppressing member 64 is mounted on the prosthetic leg 52 as a prosthetic body has been described. However, the present invention is not limited to the prosthetic leg 52 and can be similarly applied to a prosthetic hand as a prosthetic body.

上述した例では、炎症/臭い抑制部材64を義足52に適用して説明したが、ギブスにも同様に適用することができる。特に、ギブスは石膏が固まると取外しができないため、ギブス内部も足や腕などの装着部分からの汗、脂分などの分泌物より雑菌が非常に繁殖しやすく、ギブス内部の環境は非常に悪い状態となる。ギブスに適用する場合、石膏を固めてギブス本体を形成する前に、骨接ぎなどの治療すべき部位の皮膚表面に包帯などによって皮膚に接着するように炎症/臭い抑制部材を保持し、その後、石膏を固めてギブス本体で治療部位を固めるようになる。このようにギブス本体の内側に炎症/臭い抑制部材64を設けた場合にも、その抗菌作用によって雑菌の繁殖が抑えられ、ギブス内部の環境を改善することができる。   In the above-described example, the inflammation / odor suppressing member 64 is applied to the prosthetic leg 52, but the present invention can be applied to the cast. In particular, Gibbs cannot be removed when plaster is hardened, so it is easy for bacteria to propagate inside the Gibbs from secretions such as sweat and fat from the wearing parts such as feet and arms, and the environment inside the Gibbs is very bad. It becomes a state. When applying to a cast, before the gypsum is solidified to form the cast body, an inflammation / odor control member is held on the surface of the skin to be treated, such as a bone joint, so that it adheres to the skin with a bandage, etc. The treatment site is solidified with the cast body. As described above, even when the inflammation / odor control member 64 is provided inside the gibbs body, the antibacterial action suppresses the propagation of various germs, and the environment inside the gibbs can be improved.

〔実施例及び比較例〕
実施例1
炎症/臭い抑制部材の効果を確認するために、アルミ箔の母材本体に次の通りの条件にて表面処理を行った。
実施例1として図1に示す表面処理装置を用い、硫酸100g/リットルの硫酸浴に硫酸銀5g/リットルを添加した電解液を用いて電解処理を行った。母材本体としてアルミ箔(縦50mmX横50mmX厚さ0.08mm)を用い、このアルミ箔を陽極(プラス)側とし、カーボン電極を陰極(マイナス)側とした。電解処理中の電解液の温度は15℃であり、電解処理中、交流と直流の電流比を1:1とした交直重畳の電流を加えた。この電解電流の電流密度は1.0A/dm であり、上記の条件で電解処理を10分行い、アルミ箔の表面に陽極酸化被膜(厚さ:2μm)を形成するとともに、この陽極酸化被膜に銀を析出させた。その後、この表面処理を行ったアルミ箔にメッシュ400#の不織布を両側から挟んでプレス加工を施し、アルミ箔の両面に不織布を圧着させて炎症/臭い抑制部材を製造した(実施例1)。
[Examples and Comparative Examples]
Example 1
In order to confirm the effect of the inflammation / odor control member, the aluminum foil base material was subjected to a surface treatment under the following conditions.
As Example 1, the surface treatment apparatus shown in FIG. 1 was used, and an electrolytic treatment was performed using an electrolytic solution obtained by adding 5 g / liter of silver sulfate to a sulfuric acid bath of 100 g / liter of sulfuric acid. Aluminum foil (length 50 mm × width 50 mm × thickness 0.08 mm) was used as the base material body, and this aluminum foil was the anode (plus) side and the carbon electrode was the cathode (minus) side. The temperature of the electrolytic solution during the electrolytic treatment was 15 ° C., and during the electrolytic treatment, an AC / DC superimposed current with an AC / DC current ratio of 1: 1 was applied. The current density of the electrolytic current is 1.0 A / dm 2 , and the electrolytic treatment is performed for 10 minutes under the above conditions to form an anodized film (thickness: 2 μm) on the surface of the aluminum foil. Silver was precipitated. Thereafter, the surface-treated aluminum foil was pressed by sandwiching a nonwoven fabric of mesh 400 # from both sides, and the nonwoven fabric was pressed on both sides of the aluminum foil to produce an inflammation / odor control member (Example 1).

実施例2
実施例2として実施例1と同様の表面処理装置を用い、また母材本体としてアルミニウム(材質:A1100)製のプレート(縦50mmX横50mmX厚さ1.0mm)を用い、硫酸200g/リットルの硫酸浴に硝酸銀10g/リットルを添加した電解液を用いて電解処理を行った。電解処理の条件は実施例1と同様であり、この電解処理を施してアルミプレートの表面に陽極酸化被膜を形成するとともに、この陽極酸化被膜に銀を析出させた。その後、この表面処理を行ったアルミプレートをメッシュ400#の不織布の袋状部材に入れて炎症/臭い抑制部材を製造した(実施例2)。
Example 2
As Example 2, the same surface treatment apparatus as in Example 1 was used, and a plate made of aluminum (material: A1100) (length 50 mm × width 50 mm × thickness 1.0 mm) was used as the base material body, and sulfuric acid of 200 g / liter of sulfuric acid was used. Electrolytic treatment was performed using an electrolytic solution in which 10 g / liter of silver nitrate was added to the bath. The conditions for the electrolytic treatment were the same as in Example 1. This electrolytic treatment was performed to form an anodized film on the surface of the aluminum plate, and silver was deposited on the anodized film. Then, the aluminum plate which performed this surface treatment was put into the nonwoven fabric bag-like member of mesh 400 #, and the inflammation / odor control member was manufactured (Example 2).

実施例3
実施例3として実施例1と同様の表面処理装置を用い、また母材本体として実施例1と同様のアルミ箔を用い、硫酸100g/リットルの硫酸浴に硫酸銀10g/リットルを添加した電解液を用いて電解処理を行った。電解処理の条件は実施例1と同様であり、この電解処理を施してアルミ箔の表面に陽極酸化被膜を形成するとともに、この陽極酸化被膜に銀を析出させた。その後、この表面処理を行ったアルミ箔の片面にメッシュ400♯の不織布をプレス加工により圧着させて炎症/臭い抑制部材を製造した(実施例3)。
Example 3
An electrolytic solution in which the same surface treatment apparatus as in Example 1 was used as Example 3 and the same aluminum foil as in Example 1 was used as the base material body, and 10 g / liter of silver sulfate was added to a sulfuric acid bath of 100 g / liter of sulfuric acid. Was used for the electrolytic treatment. The conditions for the electrolytic treatment were the same as in Example 1. This electrolytic treatment was performed to form an anodized film on the surface of the aluminum foil, and silver was deposited on the anodized film. Thereafter, a non-woven fabric of mesh 400 # was press-bonded to one side of the surface-treated aluminum foil by press working to produce an inflammation / odor control member (Example 3).

実施例4
実施例4として実施例1と同様の処理装置を用い、また母材本体としてアルミ繊維(縦50mmX横50mm)を用い、硫酸300g/リットルの硫酸浴に硝酸銀5g/リットルを添加した電解液を用いて電解処理を行った。電解処理の条件は実施例1と同様であり、この電解処理を施してアルミ繊維の表面に陽極酸化被膜を形成するとともに、この陽極酸化被膜に銀を析出させた。その後、この表面処理を行ったアルミ繊維をメッシュ400♯の不織布の袋状部材に入れて炎症/臭い抑制部材を製造した(実施例4)。
Example 4
Example 4 uses the same processing apparatus as Example 1, and uses an electrolytic solution in which aluminum fiber (length 50 mm × width 50 mm) is used as a base material body and silver nitrate 5 g / liter is added to a sulfuric acid bath of 300 g / liter sulfuric acid. Electrolytic treatment was performed. The conditions for the electrolytic treatment were the same as in Example 1. This electrolytic treatment was performed to form an anodized film on the surface of the aluminum fiber, and silver was deposited on the anodized film. Thereafter, the surface-treated aluminum fibers were put into a non-woven bag member of mesh 400 # to produce an inflammation / odor control member (Example 4).

実施例5
実施例5として、母材本体としてアルミニウム製のプレート(縦50mmX横50mm×厚さ1.0mm)を用い、このアルミプレートに酸化チタンを塗布して、約150℃の温度で30分間熱して酸化チタン膜を固定化して形成した。その後、この処理を行ったアルミプレートをメッシュ400♯の袋状部材に入れて炎症/臭い抑制部材を製造した(実施例5)。
Example 5
As Example 5, an aluminum plate (length 50 mm × width 50 mm × thickness 1.0 mm) was used as a base material body, titanium oxide was applied to the aluminum plate, and the plate was heated at a temperature of about 150 ° C. for 30 minutes to oxidize. The titanium film was formed by immobilization. Thereafter, the aluminum plate subjected to this treatment was placed in a bag-shaped member of mesh 400 # to produce an inflammation / odor control member (Example 5).

比較例1
比較例1として、実施例1と同様の表面処理装置を用い、また母材本体として実施例2と同様のアルミプレートを用い、硫酸150g/リットルの硫酸浴を用いて電解処理を行った。電解処理の条件は実施例1と同様であり、この電解処理を行ってアルミプレートの表面に陽極酸化被膜を形成した。その後、この表面処理を行ったアルミプレートをメッシュ400♯の不織布の袋状部材に入れて製造したものを比較例1とした。
Comparative Example 1
As Comparative Example 1, the same surface treatment apparatus as in Example 1 was used, the same aluminum plate as in Example 2 was used as the base material body, and electrolytic treatment was performed using a sulfuric acid bath of 150 g / liter of sulfuric acid. The conditions for the electrolytic treatment were the same as in Example 1. This electrolytic treatment was performed to form an anodized film on the surface of the aluminum plate. Thereafter, the aluminum plate subjected to the surface treatment was put in a non-woven bag-like member of mesh 400 #, and was produced as Comparative Example 1.

比較例2
比較例2として純銅のプレートを用いた。プレートの大きさは実施例2のアルミプレートの母材本体と同じ(縦50mmX横50mmX厚さ1.0mm)であった。この純銅のプレートをメッシュ400の不織布の袋状部材に入れて製造したものを比較例2とした。
Comparative Example 2
As Comparative Example 2, a pure copper plate was used. The size of the plate was the same as the base metal body of the aluminum plate of Example 2 (length 50 mm × width 50 mm × thickness 1.0 mm). A comparative example 2 was prepared by putting this pure copper plate into a non-woven bag member of mesh 400.

脚の切断端部のかぶれ、痒みなどの抑制確認試験
実施例1〜5並びに比較例1及び2を用いて脚及び手の切断端部におけるかぶれ、痒みの抑制確認試験を行った。実施例1及び3では、不織布が皮膚に密着接触するように脚及び手の切断端部(断端足部、断端手部)に粘着テープで直接的に取り付け、実施例2、4及び5並びに比較例1及び2では、不織布が皮膚に接触するように義足及び義手の装着ソケットの内周面に装着した。実施例1〜5並びに比較例1及び2のものを上述したように用いたときの脚及び手の切断面のかぶれ、かゆみの発生状況と、幻肢(痛み、かゆみ)の発生状況とを調べた。脚及び腕の切断端部のかぶれ、かゆみの発生状況の結果は、表1に示す通りであり、また幻肢の発生状況の結果は、表2に示す通りであった。
Suppression confirmation test such as rash and itching at the cut end of the leg Using Examples 1 to 5 and Comparative Examples 1 and 2, a suppression check test for rash and itch at the cut end of the leg and the hand was performed. In Examples 1 and 3, the nonwoven fabric was directly attached to the cut ends of the legs and hands (stump feet, stump hands) with adhesive tape so that the nonwoven fabric was in close contact with the skin, and Examples 2, 4, and 5 were used. In Comparative Examples 1 and 2, the nonwoven fabric was mounted on the inner peripheral surface of the mounting socket for the artificial leg and the prosthetic hand so that the nonwoven fabric was in contact with the skin. Examination of the occurrence of rash and itching of the cut surfaces of the legs and hands when using Examples 1 to 5 and Comparative Examples 1 and 2 as described above, and the occurrence of phantom limbs (pain, itching) It was. The results of the occurrence of rash and itching at the cut ends of the legs and arms are as shown in Table 1, and the results of the occurrence of phantom limbs are as shown in Table 2.

Figure 2005287985
Figure 2005287985
表1の結果から理解されるように、実施例1〜4を用いた義足及び義手ではいずれも30日間使用しても足及び手の切断端部の皮膚のかぶれ、かゆみは発生せず、実施例5では、使用から22日目でかぶれ、かゆみが少し発生したが、30日目でもかぶれ、かゆみの程度は少しであった。これに対して、比較例1では使用から7日目でかぶれ、かゆみが大きく発生し(7日目以降の使用を中止した)、また比較例2では使用から7日目でかぶれ、かゆみが少し発生し、14日目でかぶれなどが大きくなった(14日目以降の使用を中止した)。これらの結果から、比較例1及び2では皮膚のかぶれ、かゆみの発生をほとんど抑制することができないが、実施例5では酸化チタン膜から発生する活性酸素の消臭抗菌作用によりある程度皮膚の状態を改善することができ、また実施例1〜4では、いずれも、析出した銀の抗菌作用により皮膚のかぶれ、かゆみの発生を充分に抑え、1カ月使用しても皮膚のかぶれ、痒みが発生せず、皮膚の状態を大幅に改善できることが確認できた。
Figure 2005287985
Figure 2005287985
As can be understood from the results in Table 1, both the prosthetic leg and the prosthetic hand using Examples 1 to 4 did not cause skin irritation and itching at the cut end of the foot and hand even when used for 30 days. In Example 5, the rash and itching occurred slightly on the 22nd day after use, but the rash and itchiness were slight even on the 30th day. In contrast, in Comparative Example 1, irritation and itchiness occurred significantly on the 7th day after use (use was stopped after 7th day), and in Comparative Example 2 rash was observed on the 7th day after use, and there was a slight itchiness. Occurred and rashes increased on the 14th day (use stopped after the 14th day). From these results, in Comparative Examples 1 and 2, the occurrence of skin irritation and itching can hardly be suppressed, but in Example 5, the skin condition to some extent is achieved by the deodorizing and antibacterial action of active oxygen generated from the titanium oxide film. In Examples 1 to 4, it is possible to sufficiently prevent the occurrence of skin irritation and itching due to the antibacterial action of the precipitated silver, and skin irritation and itching may occur even after one month of use. It was confirmed that the skin condition could be greatly improved.

また、幻肢痛の発生についても、表2の結果から理解されるように、実施例1〜4を装着した義足及び義手ではいずれも30日間使用しても幻肢痛は発生せず、幻肢痛の発生を大幅に改善することができ、また実施例5では22日目に幻肢痛が時々発生し、30日目でも同程度の幻肢痛の発生程度であり、幻肢痛の発生をある程度改善することが確認できたが、比較例1及び2については幻肢痛の発生の改善はほとんど見られなかった。   In addition, regarding the occurrence of phantom limb pain, as understood from the results in Table 2, the phantom limb pain does not occur even when used for 30 days on the prosthetic leg and the prosthetic hand to which Examples 1 to 4 are worn. The occurrence of limb pain can be greatly improved. In Example 5, phantom limb pain sometimes occurs on the 22nd day, and the same level of phantom limb pain occurs on the 30th day. Although it was confirmed that the occurrence was improved to some extent, in Comparative Examples 1 and 2, there was hardly any improvement in the occurrence of phantom limb pain.

表1及び表2を対比することによって理解されるように、幻肢痛の発生と、皮膚のかぶれ、かゆみの発生との間には相関関係が見られ、皮膚のかぶれ、かゆみの発生が幻肢痛の発生原因の一つと考えられ、皮膚のかぶれ、痒みを抑えることによって、幻肢による痛み、かゆみも抑えられると思われる。   As can be seen by comparing Table 1 and Table 2, there is a correlation between the occurrence of phantom limb pain and the occurrence of skin irritation and itching, and the occurrence of skin irritation and itching is an illusion. It is thought to be one of the causes of limb pain. By suppressing skin irritation and itching, pain and itch caused by phantom limbs can also be suppressed.

このような炎症/臭い抑制部材は抗菌作用を有する故に、使用することによって、雑菌の繁殖を抑えて清潔な状態に保つことができ、皮膚に密着させて保持することによって皮膚のかぶれ、かゆみの発生を抑制することができ、また臭いの発生も抑制することができる。この炎症/臭い抑制部材は義手、義足及び義手に用いて装着者の皮膚のかぶれ、かゆみの発生を抑えるとともに、臭いの発生も抑えることができ、義手、義足を清潔に保って使用による不快感を解消することができる。このように、炎症/臭い抑制部材は、プレート状、繊維状などの各種形状に形成することによって、皮膚の炎症(かぶれ、かゆみ)を抑えるために、及び/又は臭いの発生を抑えるために各種物品に広く適用することができる。   Since such an inflammation / odor control member has an antibacterial action, it can be used to suppress the propagation of germs and keep it clean, and by keeping it in close contact with the skin, it can cause skin irritation and itching. Generation | occurrence | production can be suppressed and generation | occurrence | production of an odor can also be suppressed. This inflammation / odor control member can be used on prosthetic hands, prosthetic limbs and prosthetic hands to reduce the occurrence of rashes and itching on the wearer's skin, as well as to suppress the generation of odors. Can be eliminated. As described above, the inflammation / odor control member is formed in various shapes such as a plate shape and a fiber shape so as to suppress skin inflammation (rash, itchiness) and / or to suppress the generation of odor. It can be widely applied to articles.

本発明に従う炎症/臭い抑制部材の製造方法を実施するための表面処理装置の一例を簡略的に示す簡略図である。It is a simplification figure showing simply an example of a surface treatment device for carrying out a manufacturing method of an inflammation / smell control member according to the present invention. 図1の表面処理装置により表面処理した母材本体の一部を示す部分拡大断面図である。It is the elements on larger scale which show a part of base material main body surface-treated with the surface treatment apparatus of FIG. 本発明に従う炎症/臭い抑制部材の一例を示す断面図である。It is sectional drawing which shows an example of the inflammation / odor suppression member according to this invention. 図3の炎症/臭い抑制部材を分解して示す斜視図である。It is a perspective view which decomposes | disassembles and shows the inflammation / odor suppression member of FIG. 本発明に従う義体の一例としての義足を簡略的に示す断面図である。It is sectional drawing which shows simply the artificial leg as an example of the artificial body according to this invention.

符号の説明Explanation of symbols

2 電解槽
4,6 電極
12,14 母材本体
16 直流電源
18 交流電源
22 陽極酸化被膜
24 バリア層
26 多硬質層
30 析出金属
32 不織布
52 義足
54 装着ソケット
56 足部
64 炎症/臭い抑制部材
2 Electrolyzer 4, 6 Electrode 12, 14 Base material body 16 DC power supply 18 AC power supply 22 Anodized film 24 Barrier layer 26 Multi-hard layer 30 Deposited metal 32 Non-woven fabric 52 Prosthetic leg 54 Mounting socket 56 Foot 64 Inflammation / odor control member

Claims (6)

アルミニウム又はその合金から形成された母材本体の表面の少なくとも一部に陽極酸化被膜を設け、前記陽極酸化被膜の少なくとも一部に銀、銅、金及び白金のいずれか一種又は二種以上の金属を析出させ、前記母材本体の表面の少なくとも一部を不織布で覆ったことを特徴とする炎症/臭い抑制部材。   An anodized film is provided on at least a part of the surface of the base material main body formed from aluminum or an alloy thereof, and at least a part of the anodized film is one or more metals of silver, copper, gold and platinum Inflammation / odor control member, wherein at least a part of the surface of the base material body is covered with a nonwoven fabric. 母材本体の表面の少なくとも一部に酸化チタン膜を設け、前記母材本体の表面の少なくとも一部を不織布で覆ったことを特徴とする炎症/臭い抑制部材。   An inflammation / odor control member, wherein a titanium oxide film is provided on at least a part of a surface of a base material body, and at least a part of the surface of the base material body is covered with a nonwoven fabric. 請求項1又は2に記載の炎症/臭い抑制部材と、人体の一部に装着するための装着ソケットとを備え、前記炎症/臭い抑制部材を前記装着ソケットの内面に装着して皮膚表面に不織布を介して保持し、前記炎症/臭い抑制部材の析出金属又は酸化チタン膜の抗菌作用により皮膚表面の炎症発生を抑制し、前記装着ソケット内の臭い発生を抑制することを特徴とする義体。   3. An inflammation / odor control member according to claim 1 and a mounting socket for mounting on a part of a human body, wherein the inflammation / odor control member is mounted on the inner surface of the mounting socket, and a nonwoven fabric is formed on the skin surface. The prosthetic body is characterized by suppressing the generation of inflammation on the skin surface by the antibacterial action of the deposited metal or titanium oxide film of the inflammation / odor control member, and suppressing the generation of odor in the mounting socket. 請求項1又は2に記載の炎症/臭い抑制部材と、人体の一部に装着されるギブス本体とを備え、前記炎症/臭い抑制部材を前記ギブス本体の内面側に配設して皮膚表面に不織布を介して保持し、前記炎症/臭い抑制部材の析出金属又は酸化チタン膜の抗菌作用により皮膚表面の炎症発生を抑制し、前記ギブス本体内の臭い発生を抑制することを特徴とするギブス。   An inflammation / odor control member according to claim 1 and a Gibbs body attached to a part of a human body, wherein the inflammation / odor control member is disposed on the inner surface side of the Gibbs body on the skin surface. A gibbs that is held through a non-woven fabric, suppresses the occurrence of inflammation on the skin surface by the antibacterial action of the deposited metal or titanium oxide film of the inflammation / odor control member, and suppresses the generation of odor in the main body of the cast. アルミニウム又はその合金から形成された母材本体を、硫酸浴又はシュウ酸浴或いはこれらの混合浴中に硝酸銀、硫酸銀、硝酸銅及び硫酸銅のいずれか、或いは硝酸銀又は硫酸銀と硝酸銅又は硫酸銅との混合物を添加した電解液中にて、交直重畳電流、マイナス波を流すPR電流、又はマイナス波を流すパルス若しくは交流電流のいずれかを加えて電解処理し、これによって、前記部材本体の表面に陽極酸化被膜を形成すると同時に、添加した硝酸銀、硫酸銀、硝酸銅又は硫酸銅の金属をこの陽極酸化被膜に析出させ、その後、このように表面処理した母材本体の表面の少なくとも一部に不織布を設けたことを特徴とする炎症/臭い抑制部材の製造方法。   A base material body made of aluminum or an alloy thereof is placed in a sulfuric acid bath, an oxalic acid bath, or a mixed bath thereof, either silver nitrate, silver sulfate, copper nitrate and copper sulfate, or silver nitrate or silver sulfate and copper nitrate or sulfuric acid. In an electrolytic solution to which a mixture with copper is added, either an AC / DC superimposed current, a PR current that flows a negative wave, or a pulse or an alternating current that flows a negative wave is applied to perform electrolytic treatment, At the same time as forming the anodic oxide coating on the surface, the added silver nitrate, silver sulfate, copper nitrate or copper sulfate metal is deposited on the anodic oxide coating, and then at least part of the surface of the base material main body thus surface-treated. A method for producing an inflammation / odor control member, characterized in that a nonwoven fabric is provided on the surface. アルミニウム又はその合金から形成された母材本体を、硫酸浴又はシュウ酸浴或いはこれらの混合浴中に浸漬してその表面に陽極酸化被膜を形成し、その後、硝酸銀、硫酸銀、硝酸銅及び硫酸銅のいずれか、或いは、硝酸銀又は硫酸銀と硝酸銅又は硫酸銅との混合物を添加した電解液中にて、交直重畳電流、マイナス波を流すPR電流、マイナス波を流すパルス又は交流電流のいずれかを加えて電解処理し、これによって、添加した硝酸銀、硫酸銀、硝酸銅又は硫酸銅の金属を陽極酸化被膜に析出させ、次いで、このように表面処理した母材本体の表面の少なくとも一部に不織布を設けたことを特徴とする炎症/臭い抑制部材の製造方法。   A base material body formed of aluminum or an alloy thereof is immersed in a sulfuric acid bath, an oxalic acid bath or a mixed bath thereof to form an anodized film on the surface, and then silver nitrate, silver sulfate, copper nitrate and sulfuric acid are formed. Any of copper, or an AC / DC superimposed current, a PR current for passing a negative wave, a pulse for flowing a negative wave, or an alternating current in an electrolyte to which a mixture of silver nitrate or silver sulfate and copper nitrate or copper sulfate is added In this way, the added silver nitrate, silver sulfate, copper nitrate or copper sulfate metal is deposited on the anodized film, and then at least a part of the surface of the base material body thus surface-treated. A method for producing an inflammation / odor control member, characterized in that a nonwoven fabric is provided on the surface.
JP2004110713A 2004-04-05 2004-04-05 Inflammation/odor suppressing member, manufacturing method thereof, and prosthesis and cast using it Pending JP2005287985A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004110713A JP2005287985A (en) 2004-04-05 2004-04-05 Inflammation/odor suppressing member, manufacturing method thereof, and prosthesis and cast using it

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004110713A JP2005287985A (en) 2004-04-05 2004-04-05 Inflammation/odor suppressing member, manufacturing method thereof, and prosthesis and cast using it

Publications (1)

Publication Number Publication Date
JP2005287985A true JP2005287985A (en) 2005-10-20

Family

ID=35321581

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004110713A Pending JP2005287985A (en) 2004-04-05 2004-04-05 Inflammation/odor suppressing member, manufacturing method thereof, and prosthesis and cast using it

Country Status (1)

Country Link
JP (1) JP2005287985A (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010508356A (en) * 2006-10-30 2010-03-18 マクニール−ピーピーシー・インコーポレイテッド Inhibition of enzyme activity using nanoparticles
US7695522B2 (en) 2002-04-16 2010-04-13 Accentus Plc Metal implants
JP2012514483A (en) * 2009-01-05 2012-06-28 ドット ゲーエムベーハー Method for producing an anti-infectious coating on an implant
JP2014503693A (en) * 2011-01-14 2014-02-13 アクセンタス メディカル リミテッド Metal processing
US8858775B2 (en) 2007-10-03 2014-10-14 Accentus Medical Limited Method of manufacturing metal with biocidal properties
US9011665B2 (en) 2004-03-13 2015-04-21 Accentus Medical Limited Metal implants
KR20200111920A (en) * 2019-03-20 2020-10-05 (주)포스메디칼 Thermoplastic gips for medical

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7695522B2 (en) 2002-04-16 2010-04-13 Accentus Plc Metal implants
US8945363B2 (en) 2002-04-16 2015-02-03 Accentus Medical Limited Method of making metal implants
US9393349B2 (en) 2002-04-16 2016-07-19 Accentus Medical Limited Metal implants
US9011665B2 (en) 2004-03-13 2015-04-21 Accentus Medical Limited Metal implants
JP2010508356A (en) * 2006-10-30 2010-03-18 マクニール−ピーピーシー・インコーポレイテッド Inhibition of enzyme activity using nanoparticles
US8858775B2 (en) 2007-10-03 2014-10-14 Accentus Medical Limited Method of manufacturing metal with biocidal properties
JP2012514483A (en) * 2009-01-05 2012-06-28 ドット ゲーエムベーハー Method for producing an anti-infectious coating on an implant
US8828552B2 (en) 2009-01-05 2014-09-09 Dot Gmbh Method for producing an anti-infective coating on implants
JP2014503693A (en) * 2011-01-14 2014-02-13 アクセンタス メディカル リミテッド Metal processing
KR20200111920A (en) * 2019-03-20 2020-10-05 (주)포스메디칼 Thermoplastic gips for medical
KR102169261B1 (en) 2019-03-20 2020-10-23 (주)포스메디칼 Thermoplastic gips for medical

Similar Documents

Publication Publication Date Title
US7495146B2 (en) Wound dressing
AU2011244526B8 (en) Implant with antimicrobial coating
US20060015052A1 (en) Wound dressing
US20090326438A1 (en) Method for sterilizing and disinfecting body tissues by ising iontophoresis and the medical device
EP0671957A1 (en) Process for treating a metallic surgical implant
HK1123484A1 (en) Method of using oxidative reductive potential water solution in dental applications
EP1772432A1 (en) Acidic water producing device, acidic water producing method, and acidic water
US20130075267A1 (en) Metal Treatment
JP2005287985A (en) Inflammation/odor suppressing member, manufacturing method thereof, and prosthesis and cast using it
JP2016508778A (en) Ceramic body, especially for use as a dental implant
JP2007037853A (en) Sleep disorder treatment device
JP5535647B2 (en) Metal implant
JP2005137801A (en) Inflammation/odor suppressing member, its surface treatment method, and prosthetic body and shoe using the member
Wood MASKS FOR FACIAL WOUNDS.
JP2017519538A (en) Method for surface treatment of bioerodible implants
CN101451261A (en) Bacterial inhibition biological active titanium and titanium alloy implantation material as well as preparation method and use thereof
JP5463511B1 (en) Iontophoretic skin infection treatment device
JP3124401U (en) Discomfort / odor control member
JPH06154255A (en) Preparation of implant
Bhola et al. Characterization of a biomedical titanium alloy using various surface modifications to enhance its corrosion resistance and biocompatibility
KR101509322B1 (en) Membrane for dental implants and method for manufacturing thereof
KR100789704B1 (en) Nano silver contain a spine
WO2023229529A1 (en) Device and method for debriding tissue
KR200393036Y1 (en) Nano platinum mult contain a spine
TWI232112B (en) Process of preparing porcine dressing